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The presence of bacteria varies between
colorectal adenocarcinomas, precursor
lesions and non-malignant tissue
Caspar Bundgaard-Nielsen1,2, Ulrik T. Baandrup1,2,3, Lars P. Nielsen4 and Suzette Sørensen1,2*
Abstract
Background: A causal association has been suggested between certain bacteria and colorectal cancer (CRC). Only a
few studies have, however, investigated the presence of these bacteria directly in colon tissue with conflicting
results. It is thus uncertain which role they may have in prognosis and carcinogenesis of CRC.
Methods: Formalin-fixed and paraffin-embedded (FFPE) colorectal tissue samples from patients diagnosed with
colorectal cancer (CRC)(tumor and paired normal tissue, n = 99), adenomas (n = 96), or diverticular disease (n = 104)
were tested for the presence and bacterial load of Streptococcus gallolyticus (S. gallolyticus), Fusobacterium
nucleatum (F. nucleatum), and Bacteroides fragilis (B. fragilis) using quantitative PCR. A subsequent broader search
was conducted on a subset of samples using 16S ribosomal RNA gene sequencing. Finally, to evaluate the
prognostic value, the bacterial status was compared to patient outcome.
Results: S. gallolyticus was not detected by qPCR in any of the investigated tissue samples and F. nucleatum and B.
fragilis were found to be equally distributed in tumors, paired normal tissue, and diverticula, but significantly less
present in adenomas compared to both tumors and diverticula. Neither, F. nucleatum nor B. fragilis status affected
the five-year prognosis of the patients. The 16S rRNA gene sequencing data revealed that tumors were associated
with the Prevotella genus while conversely adenomas and diverticula were associated with Acinetobacter genus.
Conclusion: These findings do not support a role of F. nucleatum or B. fragilis during colorectal beginning, while S.
gallolyticus was not implicated in the colorectal tissue of a Danish population. A potential role of the bacterial
genera Prevotella and Acinetobacter was indicated, and requires further investigations.
Keywords: Colorectal cancer, Cancer microbiota, Colorectal adenomas, Fusobacterium, Bacteroides, Prevotella,
Streptococcus, Acinetobacter
Background
Colorectal cancer (CRC) is one of the most common
cancers, with approximately 1.4 million cases diagnosed
and 700.000 deaths reported annually worldwide [1].
CRC originates from mutations causing abnormal prolif-
eration in the colorectal epithelium and subsequent for-
mation of an adenomatous growth (adenoma) [2].
Through accumulation of mutations, such adenomas
may lead to CRC [3, 4]. Several risk factors are associ-
ated with development of CRC, including diet, smoking
and high alcohol consumption [5–9]. Early detection al-
lows efficient treatment of CRC, but only 40% of cases
are detected in early stage [10]. To improve diagnostics,
screening systems for CRC have been implemented in
many countries, where stool samples are analyzed for
the presence of occult blood [11]. This, unfortunately,
leads to a high number of false positive cases resulting
in negative psychosocial consequences, increased costs,
discomfort and complications related to follow-up diag-
nostic investigations [12]. Therefore, more research is
needed, in order to find sensitive biomarkers for early
non-invasive CRC detection.
A possible role for oncogenic bacteria in CRC was first
noted in 1951 [13] and again in 1974 when it was shown
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that 64% of patients suffering from Streptococcus bovis-re-
lated endocarditis, also had colonic adenomas or CRC
[14]. It was later revealed that the Streptococcus bovis sub-
type, Streptococcus gallolyticus subsp. gallolyticus (S. gallo-
lyticus) had a uniquely strong correlation with CRC.
Despite clinical associations [14–18], investigations of the
prevalence of S. gallolyticus infection directly in CRC tu-
mors have shown conflicting results [19, 20]. Recent stud-
ies have demonstrated enrichment with the bacteria
Fusobacterium nucleatum (F. nucleatum) [20–26] and
Bacteroides fragilis (B. fragilis) [27–30] in tumor tissue
and fecal material of CRC patients, while a subsequent in-
vestigation indicated that high-level colonization with F.
nucleatum or B. fragilis were indicators of poor prognosis
in CRC patients [31]. To understand the role of bacteria
in colorectal carcinogenesis, we investigated the bacterial
involvement in the healthy tissue-adenoma-carcinoma se-
quence of CRC development. Previous studies investigat-
ing precancerous adenomas, have found diverging
bacterial compositions. Enrichment of F. nucleatum has
been documented in both fecal samples from patients
with adenomas [32–34] and directly in biopsies from the
adenomas [32, 35, 36]. Conversely, Pagnini et al. [37]
found a marked reduction of mucosal adherent bacteria in
adenomas, while Shen et al. [38] did not detect F. nuclea-
tum in adenomas but only in biopsies from healthy volun-
teers. A recent study by Rezasoltani et al. [34]
demonstrated enrichment of F. nucleatum, B. fragilis and
S. bovis in tubular, villous and tubulovillous adenomas but
not in hyperplastic or serrated polyps, while in contrast,
Yu et al. [39] found serrated polyps to be more frequently
enriched with F. nucleatum compared to tubular aden-
omas. While a gradual increase in enrichment of F. nucle-
atum from healthy colorectal tissue to adenomas and
finally to CRC has been demonstrated [32, 33, 36, 40, 41],
less is known for B. fragilis [42] or S. gallolyticus.
The majority of studies investigating bacterial involve-
ment in the adenoma-carcinoma sequence were based
on fecal samples [32, 33, 40, 41]. Fecal samples are plen-
tiful and are thus often used as a non-invasive method
for investigating gut microbiota. Some variations can
however, be observed between fecal microbiota and the
microbiota of the mucosal lesion [43]. As a result, more
information is needed concerning enrichment of S. gal-
lolyticus, F. nucleatum and B. fragilis in mucosal samples
during the colorectal adenoma-carcinoma sequence.
Formalin-fixed and paraffin embedded (FFPE) tissue
blocks may serve as an abundant source of tissue, enab-
ling studies on bacterial involvement directly in the colo-
rectal tissue. In this study, we compared bacterial
colonization of archival colorectal tissue from non-
cancerous tissue, adenomas and tumors. Furthermore,
we investigated the effects of bacterial status on pa-
tient outcome.
Methods
Sample selection
Using the National Pathology Data Bank, we identified all
patients diagnosed with colorectal adenocarcinoma, colo-
rectal adenomas, and diverticular disease at the Department
of Pathology, North Denmark Regional Hospital in the
period 2002–2010. Following surgical removal, tissue sam-
ples were stored as FFPE tissue using standard procedures
for the Department of Pathology. Number of samples in-
cluded was based on sample size calculations for two pro-
portions [44], using a power of 80%, level of confidence of
95% and published prevalences of S. gallolyticus [19], F.
nucleatum [25], and B. fragilis [20] in tumor tissue com-
pared to non-neoplastic surrounding tissue. Patients diag-
nosed with more than one of the investigated lesions were
excluded. Samples containing too low DNA concentrations
or non-amplifiable DNA were excluded. We collected FFPE
tissue from 99 patients diagnosed with colorectal adenocar-
cinoma (tumors and non-neoplastic paired normal tissue),
96 patients diagnosed with colorectal adenomas, and 104
patients diagnosed with diverticular disease of the colon.
An overview of samples can be seen in Additional file 1.
Paired normal tissue was only routinely collected from tu-
mors, and thus no paired normal samples were available
from diverticula or adenomas. All samples were stored
using standard procedures at the Department of Pathology.
Sample preparation and DNA extraction
FFPE samples were collected, with each sample, including tu-
mors and paired normal tissue, occupying separate paraffin
blocks. Consecutive tissue sections were prepared from all
tissue blocks in the following order: 1 × 4 μm sections for HE
(Hematoxylin and Eosin) staining, 4 × 10μm for DNA purifi-
cation, and finally 1 × 4 μm sections for comparative HE
staining to ensure uniformity and for evaluation by a trained
pathologist. This microscope based evaluation revealed neo-
plastic cells in 23 samples of paired normal tissue and these
were therefore excluded, resulting in a total of 99 tumor tis-
sue but only 76 paired normal tissue samples being included.
To minimize the risk of cross-contaminations between sam-
ples, section knives were changed after each tissue block,
and the microtome surface wiped clean with alcohol and
RNase Away (Molecular Bioproducts). To monitor potential
carry-over of bacterial DNA between samples, an empty par-
affin block was included for every 11th patient tissue sample.
This paraffin block was freshly prepared but otherwise han-
dled similar to blocks containing tissue.
DNA was isolated from FFPE tissue sections using the
AllPrep® DNA/RNA FFPE kit (Qiagen), according to
manufacturer’s instruction.
Primer design and qPCR amplification and quantification
Quantitative real time polymerase chain reaction (qPCR)
was used to investigate presence and quantity of bacterial
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species previously associated with CRC in the different
histological tissue types. Primers targeting S. gallolyticus
species, S. gallolyticus subspecies gallolyticus, F. nuclea-
tum, and B. fragilis were designed in-house using Primer3
software, and tested for specificity using primer-BLAST
(NCBI) [45]. The qPCR sought to determine how the rela-
tive abundance of S. gallolyticus, F. nucleatum and B. fra-
gilis differed between different histological tissue types,
and thus a reference gene was designed targeting the hu-
man β-actin gene. Since DNA extracted from FFPE tissue
tends to be fragmented [46], we aimed for amplicon sizes
shorter than 200 bp. The sequences, targets, and parame-
ters of the individual primers are summarized in Table 1.
Bacterial DNA was purchased from DSMZ (Leibniz
Institute DSMZ-German Collection of Microorganisms
and Cell Cultures), including DNA from S. gallolyticus
subspecies gallolyticus (DSM 16831), S. gallolyticus
subsp. macedonicus (DSM 15879), S. gallolyticus subspe-
cies pasteurianus (DSM 15351), F. nucleatum (DSM
15643), and B. fragilis (DSM 2151). The bacterial DNA
was used for determining limit of detection (LOD) of
the individual primers using a dilution series. This was
found to be approximately 109 DNA copies for S. gallo-
lyticus spp., 10 DNA copies for S. gallolyticus subsp. gal-
lolyticus, 12 DNA copies for F. nucleatum, and 10 DNA
copies for B. fragilis. The bacterial DNA was further
used as positive control for qPCR analyses by spiking
bacterial DNA into human DNA samples extracted from
FFPE colorectal tumors to mimic the sample types used
in this study. The ratio of bacterial DNA to total human
DNA was 1:40.
qPCR was performed using the Brilliant III Ultra Fast
SYBR® Green QPCR Master Mix (Agilent Technologies)
according to manufacturer’s recommendations, and ana-
lyzed on the Mx3005P qPCR System (Agilent Technolo-
gies). All experiments were performed in triplicates
using 40 ng of input DNA with the following cycling
conditions: 95 °C for 10 min, 40 cycles of 95 °C for 1 min,
55 °C for 30 s and 72 °C for 30 s. In a few cases, several
products were apparent on the melting curve analysis,
and the PCR was then repeated using a more stringent
annealing temperature of 59 °C.
For relative quantification of bacterial DNA in samples the
ΔΔCt method [47] was applied, utilizing the primers summa-
rized in Table 1, with β-actin serving as reference gene.
Five year follow-up
The patient’s histological history was followed over a 5 year
period using the National Pathology Data Bank. Time of
death or occurrence of new cases of adenomas or cancer
in the colorectum were noted for each patient. Survival
and disease-free survival were analyzed using the Kaplan-
Meier method based on detection of bacteria. Social se-
curity numbers were not available for two patients, and
their clinical data were therefore not recorded.
16S rRNA gene sequencing
To detect other potential bacterial biomarkers, the com-
position of bacterial genera were analyzed using 16S
ribosomal RNA (rRNA) gene sequencing in a subset of
the FFPE samples already investigated in this study. A
total of 40 tissue samples were chosen using the Re-
search Randomizer software [48] to randomly select 10
samples belonging to each separate histological tissue
group (Additional file 2). Bacterial 16S rRNA amplicon
sequencing targeting the V4 variable region, was per-
formed by DNAsense (Denmark), and followed a modi-
fied version of an Illumina protocol [49]. Briefly, an
initial PCR and clean-up was performed as described by
Albertsen et al. 2015 [50] using primers targeting the V4
hypervariable region (Table 1) [51], and 35 cycles of
amplification. Next, indexing primers were attached to
all sequences using a second PCR, followed by clean-up
[49]. Finally, all samples were pooled and sequenced
Table 1 Primers used for 16S rRNA gene sequencing and qPCR analysis
Target Target gene (NCBI Accession number) Primer sequence Tm (°C) Product (bp)
Bacteria and Archaea (sequencing) V4 variable region of the 16S rRNA
(515F and 806R [51])
F: 5′-GTGCCAGCMGCCGCGGTAA-3′
R: 5′-GGACTACHVGGGTWTCTAAT-3´
65.4
49.0
~ 250–390 bpa
S. gallolyticus spp. SodA
(AP012053)
(HE613569)
(AP012054)
F: 5´-GCTTGGCTTGTGGTGAATGA-3′
R: 5′-GCGAACGTTGCGATACTTGA-3´
59.0
59.3
144
S. gallolyticus subsp. gallolyticus SodA (AP012053) F: 5´- AAGCTGCGACAACTCGCTTT − 3′
R: 5′- AAGCGTGTTCCCAAACGTCA − 3´
61.1
60.8
150
F. nucleatum 16 s ribosomal RNA (CP012717) F: 5´–CCCAAGCAAACGCGATAAGT–3′
R: 5´–GCGTTGCGTCGAATTAAACC–3´
59.2
58.9
117
B. fragilis 16 s ribosomal RNA (M11656) F: 5′- AGTAGAGGTGGGCGGAATTC − 3′
R: 5′- GTGTCAGTTGCAGTCCAGTG − 3´
59.2
59.1
97
β-actin β-actin (NG_007992) F: 5´-ACTCGTCATACTCCTGCTTGC-3′
R: 5′-CCTCCTCAGATCATTGCTCCTC-3´
60.1
60.0
118
aAmplicon length varies depending on target bacteria [51]
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using a MiSeq (Illumina, USA) as previously described
[52]. 20% PhiX control library (Illumina) was added to
estimate error rate during sequencing, a negative control
(nuclease-free water) was added to eliminate background
while a positive control (complex sample obtained from
an anaerobic digester system) were used to monitor se-
quencing efficiency and batch effects.
Bioinformatics
Quality of reads were analyzed using FastQC (Babraham
Bioinformatics, UK). Forward reads were trimmed using
Trimmomatic v0.32 [53] to remove poor reads and reads
shorter than 250 bp using the settings SLIDINGWIN-
DOW:5:3 and MINLEN:250. The reads were next derepli-
cated and processed using the UPARSE workflow [54].
The initial 250 bp of all sequencing reads were clustered
using the Usearch v. 7.0.1090 -cluster_otus command with
default settings. Operational taxonomic units (OTUs)
were formed based on 97% identity and chimeras removed
using the Usearch v. 7.0.1090 –usearch_global command
with –id 0.97. Finally, taxonomy was assigned using the
RDP classifier [55] as implemented in the parallel_assign_-
taxonomy_RDP.py script in QIIME [56] using the MiDAS
database v. 1.20 [57].
Statistics
Data analysis was performed using R version 3.5.2 [58]
through the Rstudio IDE (http://www.rstudio.com/), and
Microsoft Office Excel 2013. For continuous data,
distributions were tested using Shapiro-Wilk test. 16S
rRNA gene sequencing data was analyzed using the amp-
vis2 package v.2.3.11 [59] for Rstudio. α diversity was de-
termined using OTU richness and Shannon diversity
index as implemented in the amp_alphadiv command of
the ampvis2 packet in R. β diversity was visualized using
heat maps depicting the 20 most commonly found OTUs
and explored using Principal component analysis (PCA)
and redundancy analysis (RDA) clustering of Hellinger
Distance transformed OTU abundances. Bacterial genera
with statistical significant different distributions amongst
differing tissue types, were identified using the DESeq2
package in Rstudio [60] to generate multiple hypothesis
corrected p-values using the Benjamini-Hochberg
procedure [61]. For a bacterial genus to be considered for
further analysis, it needed to be significantly different
between tissue groups, and the difference was required to
be universal for the majority of samples in the tissue
group. That is, for a bacteria to be considered associated
with tumor tissue, it should constitute a statistically
significant higher proportion of bacteria in the majority of
tumor samples.
Categorical data, like presence or absence of bacteria,
were analyzed using χ2 test. For continuous data like
OTU richness and Shannon diversity index, distribution
was tested using Shapiro-Wilks test while variance was
tested using Bartlett’s test. Normal distributed data with
equal variance were compared using ANOVA followed
by Tukeys post-hoc test while non-parametric data were
tested using Kruskal-Wallis test followed by Dunn’s
post-hoc test. Finally, 5-year follow-up data were ana-
lyzed using the Kaplan-Meier method, and a log-rank
test were used to compare outcome between patients
positive and negative for bacterial infection.
A p value of < 0.05 was considered significant for all
statistical tests, with the exception of multiple hypothesis
corrected p values where a limit of < 0.01 was utilized.
Results
Demographic and histopathological description of patient
samples
In this study, colon samples from four different histo-
logical tissue groups were analyzed. The demographic
and histopathological characterization of these groups
are presented in Tables 2 and 3 respectively. CRC pa-
tients (71 ± 10.1 years) were significantly older (p < 0.05)
than adenoma (66 ± 11.7 years) and diverticulum pa-
tients (63 ± 14.0 years). While the location of tumor sam-
ples was more widely distributed, the majority of
adenoma and especially diverticulum samples were lo-
calized in the left colon, constituting 48.5% of CRC
tumor cases, 76.0% of adenoma cases and 89.4% of di-
verticulum cases. Information concerning age group,
gender, histologic tissue group and follow up data can be
found in Additional file 1.
S. gallolyticus was not detected in any of the investigated
tissue groups
To establish whether CRC was associated with S. galloly-
ticus, we utilized qPCR to compare the prevalence and
quantity of the bacteria in colorectal tumors, paired nor-
mal tissue, adenomas and diverticula. Surprisingly, S.
gallolyticus was below the LOD for both primers target-
ing all S. gallolyticus spp. as well as the more sensitive
primers specifically targeting S. gallolyticus subsp. gallo-
lyticus, in all tissue types (see Additional file 1).
F. nucleatum and B. fragilis were enriched in tumors
compared to adenomas, but not paired normal tissue or
diverticula
To establish the degree of colonization with F. nucleatum
and B. fragilis at different stages in the colorectal
adenoma-carcinoma sequence in CRC, we utilized qPCR
to compare the prevalence and quantity (Fig. 1) of the bac-
teria in colorectal diverticula, adenomas, tumors and
paired normal tissue. For all empty paraffin blocks, the
quantity of the tested bacteria were below the LOD of the
primer, indicating that no cross-contamination occurred.
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Table 2 Demographic characterization of the individual patient groups
Feature CRC (Tumors) CRC (paired normal tissue)a Adenomas Diverticula
Number of samples 99 76b 96 104
Age (median) 71c 70.5c 66 63
Standard deviation ± 10.1 ± 9.9 ± 11.7 ± 14.0
Age groups (%) No. (%) No. (%) No. (%) No. (%)
< 40 0 (0.0) 0 (0.0) 1 (1.0) 3 (2.9)
40–49 2 (2.0) 1 (1.3) 6 (6.3) 16 (15.4)
50–59 8 (8.1) 5 (6.6) 18 (18.8) 24 (23.1)
60–69 35 (35.4) 28 (36.8) 30 (31.3) 25 (24.0)
70–79 28 (28.3) 22 (28.9) 25 (26.0) 17 (16.3)
80–89 22 (22.2) 16 (21.1) 15 (15.6) 19 (18.3)
> 90 4 (4.0) 4 (5.3) 1 (1.0) 0 (0.0)
Gender (%) No. (%) No. (%) No. (%) No. (%)
Male 44 (44.4) 41 (53.9) 47 (48.0) 55 (52.9)
Female 55 (55.6) 35 (46.1) 51 (52.0) 49 (47.1)
aHealthy colon mucosa surrounding the tumor tissue. b 23 samples were removed following examination of the HE stained sections by a trained pathologist, due
to presence of cancer cells. cpatients donating tumors and paired normal tissue are significantly older than those with adenomas or diverticula
Table 3 Histopathological description of the four tissue groups
Tissue group Locationa Disease State
CRC (tumor)
(n = 99)
Location n (%) Tumor stageb n (%)
Right colon 49 (49.5%) I 7 (7.1%)
Left colon 48 (48.5%) II 41 (41.4%)
Rectum 2 (2.0%) III 43 (43.4%)
Not reported 0 (0.0%) IV 8 (8.1%)
CRC (paired normal tissue)
(n = 76)
Location n (%) Tumor stageb n (%)
Right colon 41 (53.9%) I 7 (9.2%)
Left colon 34 (44.7%) II 29 (38.2%)
Rectum 1 (1.3%) III 32 (42.1%)
Not reported 0 (0.0%) IV 8 (10.5%)
Adenomas
(n = 96)
Location n (%) Subtype n (%)
Right colon 15 (15.6%) Villous 1 (1.0%)
Left colon 73 (76.0%) Tubulovillous 6 (6.3%)
Rectum 3 (3.1%) Tubular 89 (92.7%)
Not reported 5 (5.2%) Dysplasia n (%)
Mild 11 (11.5%)
Moderate 55 (57.3%)
Severe 30 (31.3%)
Diverticula (n = 104) Location n (%) Inflammation n (%)
Right colon 4 (3.8%) Diverticulosis 23 (22.1%)
Left colon 93 (89.4%) Diverticulitis 81 (77.9%)
Rectum 0 (0.0%)
Not reported 7 (6.7%)
aLocation of tissue samples in the colorectal tract, based on the proposed distinction described by Bufill et al. [73]. b Tumor classification based on the
recommendations of International Union Against Cancer [74]
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F. nucleatum could be detected in 29.3% of tumor
samples and B. fragilis in 36.4% of cases (Fig. 1a). These
distributions were comparable to those found in paired
normal tissue and non-malignant diverticula, except for
B. fragilis which was detected in a higher proportion of
paired normal tissue samples (52.6%, p < 0.05). The pres-
ence of F. nucleatum and B. fragilis were furthermore
comparable when stratifying tumor samples based on
cancer stages (Fig. 1b). For tumors, paired normal tissue
and diverticula, the bacterial loads of F. nucleatum and
B. fragilis were comparable (Fig. 1c). Intriguingly, we de-
tected F. nucleatum and B. fragilis significantly less com-
mon in adenoma tissue (3.0 and 5.9% respectively)
compared to both tumor tissue (29.3 and 36.4%, p < 0.001)
and diverticula (31.7 and 44.2%, p < 0.001)(Fig. 1a). In
addition, the adenomas contained significantly less B. fra-
gilis DNA compared to diverticula (p < 0.05)(Fig. 1c).
Overall, neither F. nucleatum nor B. fragilis were
found to be specifically associated with tumors of CRC
patients, but both bacteria were noted by their low pres-
ence in adenomas.
F. nucleatum and B. fragilis status do not affect survival or
disease-free survival of patients over a five year period
To assess the clinical significance of F. nucleatum and B.
fragilis, information on disease progression and survival
were collected for all patients for a 5 year period follow-
ing initial diagnosis. A Kaplan-Meier analysis was per-
formed to examine the relationship between bacterial
status in the investigated patients, with survival and risk
of developing new cases of CRC or adenomas (Fig. 2).
Detection of F. nucleatum or B. fragilis did not result in
significant (p > 0.05) changes in survival or disease-free
survival rates of patients within a 5 year period.
Bacterial composition of tumor tissue overlaps with that
of paired normal tissue, but differs from adenoma and
diverticula
To determine if CRC tissue from the four groups (CRC
tumors, paired normal tissue, diverticula, and adenomas)
differed in overall bacterial composition, we applied a
more global approach using 16S rRNA gene sequencing.
A subsection of 10 samples from each group were ran-
domly selected and analyzed. Following quality filtering
and chimera removal, 566,527 16S rRNA sequence reads
(mean number per sample: 16,186.5 ± 4814 reads) were
obtained. A total of 696 unique Operational Taxonomic
Units (OTUs) were identified, with 97.99% being identi-
fied on the phylum taxonomic level and 63.51% on the
genus level. One sample from the adenomas and four
paired normal tissue yielded less reads than the negative
controls (3045 and 3123 reads) and were thus excluded,
resulting in a total of 35 samples (10 tumors, 6 paired
normal tissue, 9 adenomas and 10 diverticula) being
analyzed. A rarefication curve was produced, showing
good sequencing coverage (data not shown).
We first investigated bacterial richness and diversity of
the four tissue types (Fig. 3). No significant differences
were observed between either tissue types for either
OTU richness (Fig. 3a) or Shannon diversity index
(Fig. 3b), although diverticula had a slightly higher OTU
richness compared to all other tissue types. β diversity
was established to determine differences and similarities
in bacterial composition between the tissue types. Inter-
estingly, the differences between bacterial compositions
were minor as indicated by clustering on the PCA plot
(Fig. 4a). These minor changes were elucidated through
a subsequent RDA plot that reveal limited tissue specific
clustering (Fig. 4b). Tumor tissue clustered separately
from diverticula and adenoma tissue, but was highly
similar to paired normal tissue.
Differences in proportion of Prevotella and Acinetobacter
defines tissue from CRC samples versus adenoma and
diverticula
We next sought to identify the bacteria that differed be-
tween the investigated subsection of colorectal tissue
samples (Fig. 5a). Of especial note are the genera Prevo-
tella and Acinetobacter. Prevotella is a dominant bacteria
in several samples from tumors and paired normal tis-
sue, but markedly absent from especially adenoma but
also diverticula (p < 0.01). Acinetobacter are conversely
not represented in tumor or paired normal tissue, but
are dominant in the majority of samples originating
from adenomas or diverticula (p < 0.01). Despite the
Streptoccocus species S. gallolyticus being below the
LOD for all samples investigated in this study, the genus
Streptococcus was significantly more common in tumor
tissue compared to paired normal tissue, diverticula and
adenomas (p < 0.01). The genus Fusobacterium was sig-
nificantly more common in tumor tissue compared to
adenomas (p < 0.01), but not paired normal tissue nor
diverticula (p > 0.05), while no differences were observed
in composition of the Bacteroides genus between any tis-
sue types investigated (p > 0.05). We observed that a
high composition of the genera Fusobacterium and Bac-
teroides using sequencing (Fig. 5a) did not clearly correl-
ate with detection of the bacterial species F. nucleatum
or B. fragilis using qPCR (Fig. 5b).
Discussion
In recent years, there has been a growing number of re-
ports concerning a possible link between different bacter-
ial species and the development of CRC. Several bacteria
have been implicated, including S. gallolyticus [15, 17–19],
F. nucleatum [20–22, 62] and B. fragilis [27–29, 63]. To
investigate changes in the bacterial composition along the
colorectal healthy tissue-adenoma-carcinoma sequence,
Bundgaard-Nielsen et al. BMC Cancer          (2019) 19:399 Page 6 of 13
we performed qPCR and 16S rRNA gene sequencing on
FFPE tissue from colorectal diverticula, adenomas, tumors
and paired normal tissue.
Adenomas harbored a distinct bacterial community
compared to non-malignant controls, which has been
supported by others [35, 37, 38]. While the genus
Fig. 1 Presence and quantity of F. nucleatum and B. fragilis in colorectal tissue. qPCR determination of presence and quantity of bacterial DNA in
99 colorectal tumor tissue, 76 paired normal tissue, 96 adenomas and 104 diverticula. a Prevalence of F. nucleatum and B. fragilis in colorectal
tissue. Positivity was determined as bacterial species with a DNA quantity above the LOD of the primers. b Prevalence of F. nucleatum and B.
fragilis in different stages of CRC. No statistical significant differences were observed. c Difference in quantity of F. nucleatum and B. fragilis DNA in
colorectal tumor tissue compared to paired normal tissue, adenomas and diverticula as well as in adenomas compared to diverticula. Brackets
denote standard deviation. * P < 0.05, ** P < 0.001
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Acinetobacter constitutes a large percentage of total bac-
teria in both diverticula and adenomas, the relative
abundance of Bacteroides, as well as the percentage of
samples positive for the species F. nucleatum and B. fra-
gilis, were reduced in adenomas compared to both diver-
ticula and paired normal tissue. The cause for this
different microbial composition is unknown, but may re-
sult from increased local inflammation during adenoma
formation, as previously indicated [37]. This increased
inflammation may result in development of a microbial
community with oncogenic potential [42, 64]. Notably,
not all adenomas transition into CRC [65], and it will
therefore be interesting, to establish whether there exists
different subtypes of adenomas with various bacterial
compositions and potential of carcinogenic progression.
During the colorectal adenoma-tumor sequence, we ob-
served a marked increase in the relative abundance of
the bacterial genus Prevotella as well as the species F.
Fig. 2 Five-year follow-up based on presence of F. nucleatum or B. fragilis. Survival (a, c, e) and disease-free survival (b, d, f) of patients presenting with
CRC (a and b, n = 99), adenomas (c and d, n = 96) or diverticula (e and f, n = 104) depending on presence or absence of F. nucleatum or
B. fragilis. Five-year follow-up data was not available for two study participants belonging to the diverticula group. These patients were
excluded from the follow-up analysis
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nucleatum and B. fragilis, all of which have previously
been shown to be associated with colorectal tumors [24,
32, 33, 36, 40–42, 66, 67]. These bacteria are known to
promote a pro-inflammatory environment [27, 32, 63,
68, 69], and may thus drive the adenoma-tumor transi-
tion by inducing local chronic inflammation. Conversely,
we observed that bacteria belonging to the genus Acine-
tobacter were absent from all samples originating from
patients diagnosed with CRC (both tumors and paired
normal tissue), while being highly abundant in both di-
verticula and adenomas. Similar observations have been
made in rectal cancer [70], and further suggests that a
Fig. 3 Gut microbiome richness and diversity between tissue types in a subsection of samples. a OTU richness and b Shannon diversity index
was compared between a subsection of the tumors, paired normal tissue, adenomas and diverticula included in this study. A total of 35 tissue
samples were investigated, with 10 tumors samples, 6 paired normal tissue, 9 adenomas and 10 diverticula
Fig. 4 Variation in bacterial composition between individual samples and tissue types. β-diversity was investigated in 35 tissue samples using a)
PCA and subsequent b) RDA plots with Hellinger Distance of OTU abundances. Colored boxes represent different tissue types
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distinct bacterial niche develops during the
adenoma-tumor transition. In contrast to previous stud-
ies [41, 42], we did not observe a difference in the per-
centage of early and late stage CRC tumor samples
positive for F. nucleatum or B. fragilis, indicating that
these bacteria do not drive tumor progression. Finally, to
elucidate the role of F. nucleatum and B. fragilis in initi-
ation and progression of CRC, we investigated the 5 year
risk of new cases of adenomas, CRC or death depending
on bacterial status. In our study neither F. nucleatum
nor B. fragilis affected the risk of death or the risk of de-
veloping new adenomas or CRC in either CRC, adenoma
or diverticular disease patients. Overall our results sug-
gest that the bacterial genus Prevotella and the species
F. nucleatum and B. fragilis may play a role in the transi-
tion of adenomas to CRC, but not in initiation of aden-
omas nor in the progression from early to late stage
colorectal tumors.
Two surprising observations were noted during this
study. First, despite the noted association with CRC [14,
19, 34, 71], we did not detect S. gallolyticus in any of the
investigated tissue samples. The conflicting results could
potentially be explained through ethnic differences in
susceptibility to S. gallolyticus colonization of colorectal
mucosa or geographical differences in S. gallolyticus dis-
tribution. This is supported by similar findings by Vil-
joen et al. [20] in a South African CRC population.
Secondly, while several studies [21, 22], including the
current study, utilize paired normal tissue obtained from
CRC patients as a matched “healthy” control, we ob-
served that the bacterial composition of tumor tissue
and paired normal tissue overlapped considerably. While
more samples are needed to validate this observation, it
does question the validity of using paired normal tissue
as healthy controls when investigating bacteria of CRC.
This study has a number of limitations. First, all samples
used were fixed with formalin. Since formalin is known to
affect DNA quality [72], this may have limited our ability to
detect bacteria. Since all tissue samples were handled simi-
larly, we do not expect the formalin fixation to affect the ob-
served differences in bacterial load and prevalence between
diagnoses. A second limitation involves the previously
Fig. 5 Bacterial composition in a subsection of tissue types. The bacterial composition of the 35 samples analyzed using 16S rRNA gene
sequencing, was visualized. a Heatmap of the investigated samples. Colors represent bacterial composition, with stronger red indicating higher
percentage of total read abundance, while light blue indicate absence of the bacteria. The 20 most common bacteria are depicted on the y axis,
while the x-axis contains the 35 samples included in this analysis. b qPCR results for the investigated subsection of tissue samples. Samples
starting with “U” indicated diverticula, “P” indicate adenomas while samples starting with “K” indicate samples originating from patients diagnosed
with CRC (tumors or paired normal tissue)
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reported difficulties in extracting DNA from gram-positive
bacteria like S. gallolyticus [50]. The sequencing data re-
vealed a high proportion of gram positive bacteria including
other members of the Streptococcus genus. Thus, this limita-
tion does not explain the lack of S. gallolyticus reported in
this study. Finally, while the primers used in this study have
low LODs compared to bacterial DNA, the LODs were
established on purified DNA from bacteria, which would
have a higher quality compared to FFPE bacterial DNA
stored for up to 10 years. The true LOD of the primers in
the examined tissue samples, could therefore be higher, as
reported by Viljoen et al. [20]. This could prevent detection
of low abundance bacteria, causing us to underestimate the
bacterial colonization across all samples. This study had a
specific focus on the bacterial species F. nucleatum, B. fragi-
lis and S. gallolyticus. However, other studies have revealed
other bacteria with an unique correlation with CRC, includ-
ing Escherichia coli [63]. Future studies would need to in-
clude this bacteria as well.
Strengths of this study include the large number of
samples included, the inclusion of precursor lesions and
non-malignant tissue in addition to tumor and paired
normal tissue as well as a follow-up investigation investi-
gating the clinical relevance of the bacteria in addition
to the bacterial status.
Conclusion
Our results do not support a role of S. gallolyticus in CRC
in the Danish population. For F. nucleatum and B. fragilis,
this study does not support a role in development of aden-
omas, although the bacteria may play a role in the
adenoma-carcinoma transition. A potential role of the
genera Prevotella and Acinetobacter in colorectal carcino-
genesis was indicated, but warrants further studies.
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